Sharekhan has given Buy recommendation for Torrent Pharmaceuticals with a target price of Rs. 3400 in its research report issued on Jul 14, 2021
Sharekhan’s research report on Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited (Torrent) has emphasised on achieving sustainable and profitable growth in its annual report for FY2021 through a strategic framework and theme. Expected market share gains, therapy consolidation, therapy expansion, and sustained investment in new products would be the key driving factors. The geographies of India, Brazil and Europe have a strong growth outlook while US revenues are likely to bottom out and stage a gradual improvement going ahead.
Based on encouraging outlook for US business and strategy for sustainable growth, we maintain our Buy recommendation with a revised PT of Rs. 3,400.